Other OTC - Delayed Quote USD

UV Flu Technologies, Inc. (UVFT)

0.0001 0.0000 (0.00%)
At close: March 27 at 10:41 AM EDT
Loading Chart for UVFT
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0028
  • Volume 41
  • Avg. Volume 778
  • Market Cap (intraday) 670,820
  • Beta (5Y Monthly) -42.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers. Its products are used in hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casinos, and military installations. The company was formerly known as Northwest Chariots Incorporated and changed its name to UV Flu Technologies, Inc. in November 2009. UV Flu Technologies, Inc. was founded in 2006 and is based in Lincolnshire, Illinois.

www.uvflutech.com

1

Full Time Employees

September 30

Fiscal Year Ends

Related News

Performance Overview: UVFT

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UVFT
0.00%
S&P 500
4.14%

1-Year Return

UVFT
90.91%
S&P 500
19.55%

3-Year Return

UVFT
99.26%
S&P 500
18.68%

5-Year Return

UVFT
98.55%
S&P 500
70.99%

Compare To: UVFT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UVFT

Valuation Measures

As of 4/20/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.70

  • Enterprise Value/EBITDA

    -1.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -124.60%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    194.75k

  • Net Income Avi to Common (ttm)

    -750.44k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.28k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -11.06k

People Also Watch